Immunoreactive 15-hydroxyprostaglandin dehydrogenase (PGDH) is reduced in fetal membranes from patients at preterm delivery in the presence of infection

Placenta

Volumn 17, Issue 5-6, 1996, Pages 291-297

  Van Meir, C A ^a,c   Sangha, R K ^a   Walton, J C ^b   Matthews, S G ^a,e   Keirse, M J N C ^c,d   Challis, J R G ^a,e  

^a ST JOSEPH S HEALTH CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c LEIDEN UNIVERSITY   (Netherlands)

^d FLINDERS UNIVERSITY   (Australia)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; ANTIBODY; CYTOKERATIN; MESSENGER RNA; PROSTAGLANDIN; VIMENTIN;

ARTICLE; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; ENZYME ACTIVITY; FEMALE; FETUS MEMBRANE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION; MYOMETRIUM; PREMATURE LABOR; PRIORITY JOURNAL; STROMA CELL; TROPHOBLAST;

EID: 0029884697     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4004(96)90052-1     Document Type: Article

References (13)

1. Challis, J. R. G. & Mitchell, M. D. (1994) Basic mechanisms of pre-term labour. Research and Clinical Forums, 16, 39-52.
2. Cheng, L., Kelly, R. W., Thong, K. J., Hume, R. & Baird, D. T. (1993) The effect of mifepristone (RU486) on the immunohistochemical distribution of prostaglandin E and its metabolite in decidual and chorionic tissue in early pregnancy. Journal of Clinical Endocrinology and Metabolism, 77, 873-877.
3. Kelly, R. W. (1994) Pregnancy maintenance and parturition: the role of prostaglandin in manipulating the immune and inflammatory response. Endocrine Reviews, 15, 684-706.
4. Matthews, S. G. & Challis, J. R. G. (1995) Regulation of corticotropin-releasing hormone (CRH) and vasopressin (AVP) messenger ribonucleic acid (mRNA) expression in the developing ovine hypothalamus: effects of stress and glucocorticoids. American Journal of Physiology, (in press).
5. Mitchell, M. D. (1986) Pathways of arachidonic acid metabolism with specific application to the fetus and mother. Seminars in Perinatology, 10, 242-254.
6. Mitchell, M. D. & Trautmann, M. S. (1993) Molecular mechanisms regulating prostaglandin action. Molecular and Cellular Endocrinology, 93, C7-C10.
7. Naeye, R. L. (1992) Disorders of the placenta and decidua. In Disorders of the Placenta, Fetus, and Neonate: Diagnosis and Clinical Significance, pp. 183-247. St. Louis: Mosby Year Book.
8. Naeye, R. L. & Ross, S. M. (1982) Amniotic fluid infection syndrome. Clinics in Obstetrics and Gynecology, 9, 593-607.
9. Okazaki, T., Casey, M. C., Okita, J. R., MacDonald, P. C. & Johnson, J. M. (1981) Initiation of human parturition. XII. Biosynthesis and metabolism of prostaglandins in human fetal membranes and uterine decidua. American Journal of Obstetrics and Gynecology, 139, 373-381.
10. Riley, S. C., Walton, J. C., Herlick, J. M. & Challis, J. R. G. (1991) The localization and distribution of corticotropin-releasing hormone in human placenta and fetal membranes throughout gestation. Journal of Clinical Endocrinology and Metabolism, 72, 1001-1007.
11. Sangha, R. K., Walton, J. C., Ensor, C. M., Tai, H.-H. & Challis, J. R. G. (1994) Immunohistochemical localization, messenger ribonucleic acid abundance, and activity of 15 hydroxyprostaglandin dehydrogenase in placenta and fetal membranes during term and preterm labor. Journal of Clinical Endocrinology and Metabolism, 78, 982-989.
12. Skinner, K. A. & Challis, J. R. G. (1985) Changes in synthesis and metabolism of prostaglandins in human fetal membranes and decidua at labor. American Journal of Obstetrics and Gynecology, 151, 519-523.
13. van Meir, C. A., Matthews, S. G., Sangha, R. K., Ramirez, M. M., Walton, J. C., Keirse, M. J. N. C. & Challis, J. R. G. (1995) 15-hydroxyprostaglandin dehydrogenase (PGDH): implications in preterm labour with infection. Society for Gynecologic Investigation, Chicago Ill., Abstract O141.